A blood cell size clue may help track diabetes management
NCT ID NCT06067399
First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time
Summary
This study looks at whether a standard blood test measurement called red cell distribution width (RDW) is linked to HbA1C levels in people with type 2 diabetes. Researchers will measure RDW and HbA1C in 250 adults with uncontrolled diabetes at the start, then again after 3 and 6 months of treatment. The goal is to see if RDW changes along with blood sugar control, which could offer a new way to monitor diabetes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
New Valley University- Faculty of Medicine
RECRUITINGAl Khārjah, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a single pill tackle both fatty liver and diabetes?
- Does when you eat carbs and protein reshape blood sugar control?